Answers are grounded in this paper and cite their sources.
A series of N-terminal deletions of the mitochondrial targeting sequence of the HEM1 product, delta-aminolevulinate synthase, was constructed. Targeting ability of mutant signals was assayed in vivo by fusion to beta-galactosidase or to the mature delta-aminolevulinate synthase. In the former case, the subcellular location of the fusion proteins provided a measure of import efficiency. In the later case, constructs were tested for complementation of delta hem 1 strains. We found this complementation assay to be particularly sensitive if the delta hem 1 strain is rho-. The results of these experiments, together with experiments deleting the signal from the carboxyl end, indicate that the targeting information is encoded in non-overlapping regions of the HEM1 signal.
No takes yet. Share an insight, caveat, or question.
Haldi et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: